4//SEC Filing
Granowitz Craig B 4
Accession 0001127602-25-007530
CIK 0001062822other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:31 PM ET
Size
15.7 KB
Accession
0001127602-25-007530
Insider Transaction Report
Form 4
Granowitz Craig B
SVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-28+35,790→ 111,333 total - Exercise/Conversion
Common Stock
2025-02-28+74,227→ 185,560 total - Tax Payment
Common Stock
2025-02-28$0.67/sh−65,308$43,756→ 120,252 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−74,227→ 148,453 total→ Common Stock (74,227 underlying) - Exercise/Conversion
Common Stock
2025-02-28+27,917→ 75,543 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−27,917→ 0 total→ Common Stock (27,917 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-28−35,790→ 35,790 total→ Common Stock (35,790 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001876655
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:31 PM ET
- Size
- 15.7 KB